Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice

Addiction Biology

Volumn 18, Issue 2, 2013, Pages 263-273

  Viñals, Xavier ^a   Maldonado, Rafael ^a   Robledo, Patricia ^a,b  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Delayed alternation; dopamine; executive functions; microdialysis; saccharin intake; set shifting

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE TRANSPORTER; SACCHARIN;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; PERSEVERATION; PRIORITY JOURNAL; WORKING MEMORY;

ADRENERGIC UPTAKE INHIBITORS; ANALYSIS OF VARIANCE; ANIMALS; ATTENTION; CONDITIONING, OPERANT; CORPUS STRIATUM; CUES; DIET, HIGH-FAT; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXECUTIVE FUNCTION; FOOD PREFERENCES; HAPLORHINI; HUMANS; MALE; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; SACCHARIN;

EID: 84874406747     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00421.x     Document Type: Article

References (54)

1. Able JA, Gudelsky GA, Vorhees CV, Williams MT, (2006) 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry 59: 1219-1226.
2. Achat-Mendes C, Ali SF, Itzhak Y, (2005) Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology 30: 1128-1137. (Pubitemid 40720971)
3. Baumann MH, Wang X, Rothman RB, (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189: 407-424. (Pubitemid 44791212)
4. Bhattachary S, Powell JH, (2001) Recreational use of 3,4- methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment. Psychol Med 31: 647-658. (Pubitemid 32421966)
5. Capela JP, Carmo H, Remião F, Bastos ML, Meisel A, Carvalho F, (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39: 210-271.
6. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC, (2005) Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci 25: 532-538. (Pubitemid 40105626)
7. Colado MI, O'Shea E, Green AR, (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173: 249-263. (Pubitemid 38703798)
8. Dafters RI, (2006) Impulsivity, inhibition and negative priming in ecstasy users. Addict Behav 31: 1436-1441. (Pubitemid 44093851)
9. Dalley JW, Lääne K, Theobald DE, Peña Y, Bruce CC, Huszar AC, Wojcieszek M, Everitt BJ, Robbins TW, (2007) Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsychopharmacology 32: 1195-1206. (Pubitemid 46631979)
10. Dunnett SB, Nathwani F, Brasted PJ, (1999) Medial prefrontal and neostriatal lesions disrupt performance in an operant delayed alternation task in rats. Behav Brain Res 106: 13-28. (Pubitemid 29528483)
11. Fantegrossi WE, (2008) In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Exp Clin Psychopharmacol 16: 1-12. (Pubitemid 351305490)
12. Faure A, Haberland U, Condé F, El Massioui N, (2005) Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci 25: 2771-2780. (Pubitemid 40389235)
13. Fletcher PJ, Tenn CC, Rizos Z, Lovic V, Kapur S, (2005) Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) 183: 190-200. (Pubitemid 41609271)
14. Floresco SB, Jentsch JD, (2011) Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 36: 227-250.
15. Fornai F, Gesi M, Lenzi P, Ferrucci M, Lazzeri G, Pizzanelli C, Pellegrini A, Battaglia G, Ruggieri S, Paparelli A, (2004) Effects of repeated low doses of MDMA on EEG activity and fluoro-jade B histochemistry. Ann N Y Acad Sci 1025: 181-188. (Pubitemid 39643861)
16. Frederick DL, Paule MG, (1997) Effects of MDMA on complex brain function in laboratory animals. Neurosci Biobehav Rev 21: 67-78. (Pubitemid 27044551)
17. Gartside SE, McQuade R, Sharp T, (1996) Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo. J Pharmacol Exp Ther 279: 277-283. (Pubitemid 27166922)
18. Glennon RA, Little PJ, Rosecrans JA, Yousif M, (1987) The effect of MDMA ('Ecstasy') and its optical isomers on schedule-controlled responding in mice. Pharmacol Biochem Behav 26: 425-426. (Pubitemid 17038131)
19. Goldman-Rakic PS, (1995) Cellular basis of working memory. Neuron 14: 477-485.
20. Granado N, O'Shea E, Bove J, Vila M, Colado MI, Moratalla R, (2008) Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. J Neurochem 107: 1102-1112.
21. Granon S, Vidal C, Thinus-Blanc C, Changeux J-P, Poucet B, (1994) Working memory, response selection and effortful processing in rats with medial prefrontal lesions. Behav Neurosci 108: 883-891. (Pubitemid 24322259)
22. Harper DN, Wisnewski R, Hunt M, Schenk S, (2005) (+/-)3,4- methylenedioxymethamphetamine, d-amphetamine, and cocaine impair delayed matching-to-sample performance by an increase in susceptibility to proactive interference. Behav Neurosci 119: 455-463. (Pubitemid 40547950)
23. Histed MH, Pasupathy A, Miller EK, (2009) Learning substrates in the primate prefrontal cortex and striatum: sustained activity related to successful actions. Neuron 63: 244-253.
24. Izco M, Marchant I, Escobedo I, Peraile I, Delgado M, Higuera-Matas A, Olias O, Ambrosio E, O'Shea E, Colado MI, (2007) Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3, 4- methylenedioxymethamphetamine, 'Ecstasy') exhibit increased ethanol consumption and preference. J Pharmacol Exp Ther 322: 1003-1012. (Pubitemid 47295813)
25. Jayanthi LD, Ramamoorthy S, (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7: E728-E738.
26. Kalechstein AD, De La Garza R, Mahoney JJ, Fantegrossi WE, Newton TF, (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189: 531-537. (Pubitemid 44791222)
27. Kalivas PW, Volkow ND, (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413. (Pubitemid 41105554)
28. Kay C, Harper DN, Hunt M, (2011) The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task. Neurobiol Learn Mem 95: 473-483.
29. Kehagia AA, Murray GK, Robbins TW, (2010) Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20: 199-204.
30. Koob GF, Volkow ND, (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35: 217-238.
31. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP, (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) 144: 67-76. (Pubitemid 29242672)
32. Mayerhofer A, Kovar KA, Schmidt WJ, (2001) Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci Lett 308: 99-102. (Pubitemid 32703677)
33. Mills EM, Weaver KL, Abramson E, Pfeiffer M, Sprague JE, (2007) Influence of dietary fats on Ecstasy-induced hyperthermia. Br J Pharmacol 151: 1103-1108. (Pubitemid 47195528)
34. Monchi O, Petrides M, Mejia-Constain B, Strafella AP, (2007) Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130: 233-244. (Pubitemid 46026238)
35. Nagano-Saito A, Leyton M, Monchi O, Goldberg YK, He Y, Dagher A, (2008) Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. J Neurosci 28: 3697-3706.
36. Nawata Y, Hiranita T, Yamamoto TA, (2010) Cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy). Neuropsychopharmacology 35: 515-520.
37. Parsegian A, Glen WB Jr, Lavin A, See RE, (2011) Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry 69: 253-259.
38. Paxinos G, Franklin KBJ, (1997) The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic.
39. Plaza-Zabala A, Viñals X, Maldonado R, Robledo P, (2010) Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice. Psychopharmacology (Berl) 208: 563-573.
40. Quednow BB, Kühn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M, (2007) Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ('Ecstasy'). Psychopharmacology (Berl) 189: 517-530. (Pubitemid 44791221)
41. Reading PJ, Dunnett SB, (1991) Response disinhibition on a delayed matching to position task induced by amphetamine, nicotine and age. Psychopharmacology (Berl) 104: 137-139.
42. Ricaurte GA, Forno LS, Wilson MA, DeLanney LE, Irwin I, Molliver ME, Langston JW, (1988) (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260: 51-55.
43. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, Robbins TW, (1994) 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin card sort test: possible interactions with subcortical dopamine. J Neurosci 14: 2531-2544. (Pubitemid 24140883)
44. Robledo P, Mendizabal V, Ortuño J, de la Torre R, Kieffer BL, Maldonado R, (2004) The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors. Eur J Neurosci 20: 853-858. (Pubitemid 39036947)
45. Schenk S, Harper DN, Do J, (2011) Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals. J Psychopharmacol 25: 1043-1052.
46. Shankaran M, Gudelsky GA, (1999) A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration. Psychopharmacology (Berl) 147: 66-72. (Pubitemid 30010025)
47. Singer P, Feldon J, Yee BK, (2009) The glycine transporter 1 inhibitor SSR504734 enhances working memory performance in a continuous delayed alternation task in C57BL/6 mice. Psychopharmacology (Berl) 202: 371-384.
48. Skelton MR, Williams MT, Vorhees CV, (2006) Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. Psychopharmacology (Berl) 189: 307-318. (Pubitemid 44772814)
49. Taffe MA, Weed MR, Davis S, Huitrõn-Resendiz S, Schroeder R, Parsons LH, Henriksen SJ, Gold LH, (2001) Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology 24: 230-239. (Pubitemid 32144809)
50. Trigo JM, Cabrero-Castel A, Berrendero F, Maldonado R, Robledo P, (2008) MDMA modifies active avoidance learning and recall in mice. Psychopharmacology (Berl) 197: 391-400.
51. Wareing M, Fisk JE, Murphy P, Montgomery C, (2004) Verbal working memory deficits in current and previous users of MDMA. Hum Psychopharmacol 19: 225-234. (Pubitemid 38868338)
52. Weiss B, Stern S, Cox C, Balys M, (2005) Perinatal and lifetime exposure to methylmercury in the mouse: behavioral effects. Neurotoxicology 26: 675-690. (Pubitemid 41175901)
53. Winstanley CA, Olausson P, Taylor JR, Jentsch JD, (2010) Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res 34: 1306-1318.
54. Young JM, McGregor IS, Mallet PE, (2005) Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology 30: 1475-1482. (Pubitemid 41153119)